Antibiotic Decision Tool
Select Your Scenario
When your doctor prescribes an antibiotic, you often wonder why that specific drug was chosen over others. Cefaclor is a second‑generation cephalosporin antibiotic (often supplied as Cefaclor Monohydrate) that targets a wide range of gram‑positive and some gram‑negative bacteria.
What makes Cefaclor unique?
Cefaclor belongs to the cephalosporin class, sharing the beta‑lactam ring structure with penicillins but offering better stability against certain bacterial beta‑lactamases. It’s typically taken orally, comes in 250 mg and 500 mg tablets, and reaches peak plasma levels within an hour. Because it’s not heavily metabolized by the liver, it has a relatively clean interaction profile, which makes it a popular choice for outpatient infections.
Common clinical uses
- Acute otitis media (middle‑ear infection)
- Sinusitis
- Community‑acquired bronchitis
- Skin and soft‑tissue infections caused by susceptible organisms
In many guidelines, Cefaclor is listed as a first‑line option for these mild‑to‑moderate infections, especially when patients have penicillin allergies that are not severe.
How does Cefaclor stack up against other oral antibiotics?
Below is a side‑by‑side look at five frequently prescribed alternatives. The comparison focuses on spectrum of activity, typical dosing, common indications, side‑effect profile, cost, and emerging resistance patterns.
| Antibiotic | Spectrum | Typical Adult Dose | Key Indications | Common Side Effects | Average Cost (AU$) per 10‑day course | Resistance Concerns |
|---|---|---|---|---|---|---|
| Cefaclor | Gram‑positive & some Gram‑negative (Streptococcus, Haemophilus) | 250‑500 mg q6h | Otitis media, sinusitis, bronchitis, skin infections | Diarrhea, rash, nausea | 30‑45 | Low to moderate; stable in most regions |
| Amoxicillin | Broad Gram‑positive, limited Gram‑negative (Streptococcus, H. influenzae) | 500 mg q8h | Otitis media, sinusitis, pneumonia | GI upset, rash, rare liver enzyme rise | 12‑20 | Increasing β‑lactamase producers reduce effectiveness |
| Azithromycin | Broad, including atypicals (Mycoplasma, Chlamydia) | 500 mg day 1, then 250 mg daily x4 | Community‑acquired pneumonia, atypical infections | QT prolongation, GI upset, hepatic enzymes | 25‑35 | Emerging macrolide resistance in S. pneumoniae |
| Cephalexin | Gram‑positive (Staph, Strep); limited Gram‑negative | 250‑500 mg q6h | Skin infections, uncomplicated UTIs | Diarrhea, nausea, rash | 18‑28 | Low resistance, but not as good for H. influenzae |
| Doxycycline | Broad, including intracellular organisms | 100 mg BID | Rickettsial diseases, acne, Lyme disease | Photosensitivity, esophagitis, GI upset | 22‑30 | Generally low resistance; careful with pregnancy |
Key strengths of Cefaclor
- Effective against Haemophilus influenzae - a common cause of sinusitis and bronchitis where amoxicillin may falter.
- Oral formulation with good bioavailability (≈90%).
- Lower risk of drug‑drug interactions compared with macrolides.
When alternatives might be better
Even though Cefaclor has many advantages, certain scenarios tip the scale toward other agents:
- Severe beta‑lactamase production - If local antibiograms show high rates of β‑lactamase-producing H. influenzae, a macrolide like Azithromycin or a newer β‑lactamase‑stable cephalosporin may be preferred.
- Allergy concerns - Patients with a history of severe IgE‑mediated cephalosporin reactions should avoid Cefaclor and use a non‑β‑lactam such as Doxycycline.
- Cost sensitivity - Amoxicillin remains the most affordable first‑line choice for many community infections.
Decision guide for clinicians and patients
- Identify the likely pathogen based on infection site and local resistance data.
- Check patient’s allergy history (penicillin‑type vs. cephalosporin‑type).
- Consider pharmacokinetic needs - does the infection require high tissue penetration?
- Weigh cost and dosing convenience (once‑daily vs. q6h).
- Select the most suitable antibiotic, then reassess if symptoms persist after 48‑72 hours.
Following this flow helps you land on the right drug without over‑prescribing broad‑spectrum agents.
Potential pitfalls when using Cefaclor
- Missed doses can drop plasma levels below the MIC, fostering resistance.
- Patients with severe renal impairment may need dose adjustments - the standard 250‑500 mg q6h is for normal kidney function.
- Rare but serious Clostridioides difficile infection has been reported with any β‑lactam; monitor for persistent diarrhea.
Quick cheat‑sheet
- Best for: Mild‑to‑moderate respiratory & ear infections when H. influenzae is suspected.
- Swap out if: High local β‑lactamase rates, severe cephalosporin allergy, or cost is a barrier.
- Typical course: 7‑10 days, 250‑500 mg every 6 hours.
Frequently Asked Questions
Is Cefaclor safe for children?
Yes, Cefaclor is approved for pediatric use down to 6 months of age for indications like otitis media and sinusitis, provided the dose is adjusted by weight.
Can I take Cefaclor with antacids?
Antacids containing aluminum or magnesium may reduce Cefaclor absorption. Space the doses at least 2 hours apart.
How does Cefaclor differ from Cephalexin?
Both are cephalosporins, but Cefaclor (2nd‑gen) has better activity against Haemophilus and Moraxella, while Cephalexin (1st‑gen) is stronger against Staphylococcus aureus.
What should I do if I miss a dose?
Take the missed dose as soon as you remember, unless it’s almost time for the next one. In that case, skip the missed dose-don’t double up.
Is there a risk of cross‑reactivity with penicillin?
Cross‑reactivity is low (≈1‑2 %). Patients with a mild penicillin rash can usually tolerate Cefaclor, but those with an anaphylactic reaction should avoid it.
Armed with this comparison, you can discuss with your healthcare provider whether Cefaclor or another oral antibiotic is the best fit for your infection.
Cefaclor gets a lot of hype, but most of the time amoxicillin works just fine.